You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NBP Exercise Disclosure
Lenz Robert A. · SEC Form 4 · Filed Aug 25, 2026
Exercise
Reported value range
Not reported
Lenz Robert A. Director
NBP
Transaction date
Aug 22, 2026
Public filing date
Aug 25, 2026
Filing lag
Filed 3 days later
NBP daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 17,218 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001992908-26-000013
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Novabridge Biosciences NBP Current | Exercise | Aug 22, 2026 | Not reported |
| Novabridge Biosciences NBP | Exercise | Aug 22, 2026 | $0 |